Capstan Medical Secures $110M in Series C Funding to Advance Robotic Heart Valve Implants

Santa Cruz, CA, December 13, 2024 (Yahoo) -- Capstan Medical has raised $110 million in a Series C funding round led by Eclipse, with participation from Yu Galaxy, Intuitive Ventures, and Gideon Strategic Partners. The funding, nearly tripling its $31 million Series B from 2023, will support clinical trials for its robotic platform combining surgical robotics and catheter-based technology to provide less invasive heart valve replacement options. Capstan’s innovative approach targets mitral valve replacement, aiming to expand treatment options for cardiac disease patients through advanced robotics and catheter-guided implantation.

Read full article here.